KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) EBIT Margin: 2009-2025

Historic EBIT Margin for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to 23.09%.

  • Bausch Health Companies' EBIT Margin rose 1042.00% to 23.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.92%, marking a year-over-year increase of 467.00%. This contributed to the annual value of 16.06% for FY2024, which is 507.00% up from last year.
  • Per Bausch Health Companies' latest filing, its EBIT Margin stood at 23.09% for Q3 2025, which was up 31.56% from 17.55% recorded in Q2 2025.
  • Over the past 5 years, Bausch Health Companies' EBIT Margin peaked at 27.19% during Q3 2021, and registered a low of -12.86% during Q2 2021.
  • Its 3-year average for EBIT Margin is 14.57%, with a median of 15.03% in 2023.
  • As far as peak fluctuations go, Bausch Health Companies' EBIT Margin tumbled by 2,323bps in 2021, and later soared by 2,579bps in 2023.
  • Bausch Health Companies' EBIT Margin (Quarterly) stood at 5.07% in 2021, then crashed by 1,583bps to -10.76% in 2022, then skyrocketed by 2,579bps to 15.03% in 2023, then skyrocketed by 677bps to 21.81% in 2024, then skyrocketed by 1,042bps to 23.09% in 2025.
  • Its EBIT Margin was 23.09% in Q3 2025, compared to 17.55% in Q2 2025 and 12.22% in Q1 2025.